Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07035873 · ClinicalTrials.gov registry record · NA

Pediatric Cochlear Implant Remote Programming and Assessment

A NA study of Cochlear Implant Listeners, sponsored by Nationwide Children's Hospital.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07035873: Recruiting NA study of Cochlear Implant Listeners, sponsored by Nationwide Children's Hospital.

NCT07035873 is a NA study of Cochlear Implant Listeners that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07035873, a NA study of Cochlear Implant Listeners, is actively recruiting participants, sponsored by Nationwide Children's Hospital.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, interventional study to evaluate efficacy and end user satisfaction of remote cochlear implant programming in the pediatric population. Additionally, this study will evaluate the long-term replicability of digital audio streaming (DAS) self-assessment speech perception measures via iOS mobile application.

Primary Outcome

End user satisfaction as measured by survey of remote cochlear implant programming in the pediatric population. A variety of questions will be asked with Likert scale ratings, Scale = 1 (strongly disagree) to 5 (strongly agree), multiple choice, or open-ended questions.

Conditions Studied

Interventions

  • BEHAVIORAL Remote Programming
  • DIAGNOSTIC_TEST Remote Speech Perception

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-01-15
Est. Completion 2026-03-31
Phase NA
Nationwide Children's Hospital

188 total trials

What NCT07035873 shows while recruiting

NCT07035873 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cochlear Implant Listeners appearing as the primary indexed condition, and to 2 interventions - of which Remote Programming is the first listed.

NCT07035873 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07035873 about?

NCT07035873 is a clinical study titled "Pediatric Cochlear Implant Remote Programming and Assessment". This is a prospective, interventional study to evaluate efficacy and end user satisfaction of remote cochlear implant programming in the pediatric population. Additionally, this study will evaluate the long-term replicability of digital audio streaming (DAS) self-assessment speech perception measure...

What is the current status of trial NCT07035873?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-01-15. Estimated completion is 2026-03-31.

What conditions does trial NCT07035873 study?

This clinical trial studies the following conditions: Cochlear Implant Listeners.

What interventions are being tested in trial NCT07035873?

The interventions under investigation include: Remote Programming (BEHAVIORAL), Remote Speech Perception (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07035873?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07035873 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07035873's enrollment target sits among peer trials

15 1882nd of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07035873, the US trial registry maintained by the National Library of Medicine. NCT07035873 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.